Mighty mice: Transgenic technology 'knocks out' questions of matrix metalloproteinase function

Matrix Biology

Volumn 15, Issue 8-9, 1997, Pages 527-533

  Shapiro, Steven D ^a  

^a Div of Resp and Critical Care Med   (United States)

Author keywords

Matrix metalloproteinases; Pulmonary emphysema

Indexed keywords

MATRIX METALLOPROTEINASE;

ARTICLE; ENZYME ACTIVITY; GENE LOSS; GENE TECHNOLOGY; INFLAMMATORY CELL; LUNG EMPHYSEMA; MAMMAL; MOUSE; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

MAMMALIA; MUS MUSCULUS;

EID: 0030890685     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(97)90027-5     Document Type: Short Survey

References (34)

1. American Thoracic Society Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care Med. 152:1995;S77-S120.
2. Barinaga M. Knockout mice: Round two. Science. 265:1994;26-28.
3. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med. 4:1993;197-250.
4. D'Armiento J., Dalal S.S., Okada Y., Berg R.A, Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell. 71:1992;955-961.
5. D'Armiento J., DiColandrea T., Dalal S.S., Okada Y., Huang M.Y., Conney A.H., Chada K. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15:1995;5732-5739.
6. DeClerck Y.A., Shimada H., Taylo S.M., Langley K.E. Matrix metalloproteinases and their inhibitors in tumor progression. Ann. NY Acad. Sci. 732:1994;222-232.
7. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77:1995;863-868.
8. Erickson H.P. Gene knockouts of c-src, transforming growth factorβ1, and tenascin suggest superfluous, nonfunctional expression of proteins. J. Cell Biol. 120:1993;1079-1081.
9. Gack S., Vallon R., Schaper J., Ruthers U., Angel P. Phenotypic alterations in fos-transgenic mice correlate with changes in fos/jun-dependent collagenase type 1 expression. J. Biol. Chem. 269:1994;10363-10369.
10. Gijbels K., Galardy R.E., Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94:1994;2177-2182.
11. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA plolymerase b gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
12. Heusel J.W., Wesselschmidt R.L., Shresta S., Russell J.H., Ley T.J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76:1994;989-1000.
13. Khokha R., Waterhouse P., Yagel S., Lala P.K., Overall C.M., Norton G., Denhardt T.D. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on swiss 3T3 cells. Science. 243:1989;947-950.
14. Kuhn R., Schwenk F., Auguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429.
15. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
16. Liu X., Wu H., Byrne M., Jeffrey J., Kran S., Jaenisch R. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130:1995;227-237.
17. Martel-Pelletier J., McCollum R., Fujimoto N., Obata K., Cloutier J.M., Pelletier J.P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest. 70:1994;807-815.
18. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121-125.
19. Noel A., Santavicca M., Stoll I., L'Hoi C., Staub A., Murphy G., Rio M.C., Basset P. Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J. Biol. Chem. 270:1995;22866-22872.
20. Olson E.N., Arnold H.-H., Rigby P.W.J., Wold B.J. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell. 85:1996;1-4.
21. Paigen K. A miracle enough: the power of mice. Nat. Med. 1:1995;215-220.
22. Ray J.M., Stetler-Stevenson W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Resp. J. 7:1994;2062-2072.
23. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., Martel-Pellerier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not synoviocytes. A role in osteoarthritis. J. Clin. Invest. 97:1996;2011-2019.
24. Reynolds J.J., Hembry R.M., Meikle M.C. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv. Dent. Res. 8:1994;312-319.
25. Shapiro S.D. Elastolytic metalloproteinases produced by human mononuclear phagocytes: Potential roles in destructive lung disease. Am. J. Resp. Crit. Care Med. 150:1994;S160-S164.
26. Shipley J.M., Wesselschmidt R.L., Kobayashi D.K., Ley T.J., Shapiro S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA. 93:1996;3942-3946.
27. Snider G.I. Emphysema: the first two centuries - and beyond: a historical overview with suggestions for future research: Parts 1 and 2. Am. Rev. Resp. Dis. 146:1992;1334-1344.
28. Snider G.I. Emphsema: the first two centuries - and beyond: a historical overview with suggestions for future research: Parts 1 and 2. Am. Rev. Resp. Dis. 146:1992;1615-1622.
29. Sympson C.J., Talhouk R.S., Alexander C.M., Chin J.R., Clift S.M., Bissell M.J. Targeted expression of stromelysin-1 in mammary gland provides for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125:1994;681-693.
30. Sympton C.J., Bissell M.J., Werb Z. Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Sem. Cancer Biol. 3:1995;159-163.
31. Thompson R.W., Mertens R.A., Liao S., Holmes D.R., Mecham R.P., Welgus H.G., Parks W.C. Production and localization of 92-kD gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96:1995;318-326.
32. Wang Y., Schnegelsberg P.N., Dausman J., Jaenisch R. Functional redundancy of the muscle-specific transcription factors and myogenin. Nature. 379:1996;823-825.
33. Witty J.P., Lempka T.R.J.C. Jr., Martrisian L.M. Decreased tumor formation in 7,12-dimethlybenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res. 55:1995;1401-1406.
34. Witty J.P., Wright J.H., Matrisian L.M. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell. 6:1995;1287-1303.